seperator

PD DR. CARSTEN RUDOLPH

seperator

Chief Executive Officer ad interim

  • Inventor of SNIM® RNA technology
  • Expertise in lung delivery
  • 15 Patents / Applications > 60 publications
  • Academic at LMU Munich

seperator

PD DR. CARSTEN RUDOLPH

seperator

Chief Scientific Officer

  • Inventor of SNIM® RNA technology
  • Expertise in lung delivery
  • 15 Patents / Applications > 60 publications
  • Academic at LMU Munich

seperator

PROF. DR. CHRISTIAN PLANK

seperator

Chief Technology Officer

  • Expertise in targeted drug delivery: Nucleic acids, cancer, regenerative medicine
  • 12 Patents / Applications > 90 publications
  • Professor at TU Munich

seperator

THOMAS LANGENICKEL, M.D

seperator

Chief Medical Officer

  • More than 15 years of experience in clinical development and translational medicine in cardiovascular and respiratory disease areas
  • Previously Executive Director and Head of Respiratory Profiling at Novartis AG
  • M.D. and Ph.D. at Humboldt University of Berlin
  • Clinical Pharmacology and Internal Medicine/Cardiology at the MDC and the Charité in Berlin
  • Post-doctoral fellowship at the National Heart, Lung and Blood Institute in Bethesda, USA

seperator

THOMAS LANGENICKEL, M.D

seperator

Chief Medical Officer

  • More than 15 years of experience in clinical development and translational medicine in cardiovascular and respiratory disease areas
  • Previously Executive Director and Head of Respiratory Profiling at Novartis AG
  • M.D. and Ph.D. at Humboldt University of Berlin
  • Clinical Pharmacology and Internal Medicine/Cardiology at the MDC and the Charité in Berlin
  • Post-doctoral fellowship at the National Heart, Lung and Blood Institute in Bethesda, USA

Join the Team.

CONTACT